VENATORX PHARMACEUTICALS
VenatoRx is a private pharmaceutical company focused on the discovery and development of novel anti-infectives to treat multi-drug-resistant bacterial infections and hard-to-treat viral infections. Founded in 2010, VenatoRx has built a world-class in-house R&D organization that has filed over 100 patents spanning multiple research programs. It has received significant funding awards from the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH);... Wellcome Trust; the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response (ASPR) at the U.S. Department of Health and Human Service (HHS); the U.S. Department of Defenseโs Defense Threat Reduction Agency (DTRA); and CARB-X, and as well as private equity investments from Versant Ventures, Abingworth, and Foresite Capital.
VENATORX PHARMACEUTICALS
Industry:
Biotechnology Health Care Medical Pharmaceutical
Founded:
2010-06-04
Address:
Malvern, Pennsylvania, United States
Country:
United States
Website Url:
http://www.venatorx.com
Total Employee:
51+
Status:
Active
Contact:
610-644-8935
Email Addresses:
[email protected]
Total Funding:
152.72 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics Wordpress Plugins Global Site Tag Nginx
Similar Organizations
Actinium Pharmaceuticals
Actinium Pharmaceuticals develops alpha particle linked antibodies to treat cancer.
Adamas Pharmaceuticals
Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
Adastra Pharmaceuticals
Adastra Pharmaceuticals provides responsible solutions to advance patient care in oncology.
Aquinnah Pharmaceuticals
Aquinnah Pharmaceuticals is a National Institute of Neurological Disorders and Stroke
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Cempra
Cempra develops medicines for the treatment of bacterial infections and chronic illnesses.
Debiopharm Group
Debiopharm Group is a biopharmaceutical development specialist that in-licenses promising biologics and small molecule drug.
Elite Pharmaceuticals
Elite Pharmaceuticals develops oral controlled-release products for the pain management, allergy, cardiovascular, and infection areas.
Lexicon Pharmaceuticals
Lexicon Pharmaceuticals is a biopharmaceutical company that discovers and develops precise medicines for human disease.
MicuRx Pharmaceuticals
MicuRx discovers and develops novel antibiotics to prevent and treat drug-resistant bacterial infections.
Presidio Pharmaceuticals
Presidio Pharmaceuticals discovers, develops and commercializes novel therapeutics for viral infections, including HCV and HIV.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical companyย focused on theย prevention and treatment of gastrointestinal disorders.
Serenity Pharmaceuticals
Serenity Pharmaceuticals is a developer of products that address urinary conditions.
Sound Pharmaceuticals
Sound Pharmaceuticals develops prescription drugs to prevent and treat sensorineural hearing loss.
Current Advisors List
Current Employees Featured
Founder
Investors List
AMR Action Fund
AMR Action Fund investment in Series C - Venatorx Pharmaceuticals
Abingworth
Abingworth investment in Series C - Venatorx Pharmaceuticals
CARB-X
CARB-X investment in Grant - Venatorx Pharmaceuticals
National Institute of Allergy and Infectious Diseases
National Institute of Allergy and Infectious Diseases investment in Grant - Venatorx Pharmaceuticals
Defense Threat Reduction Agency (DTRA)
Defense Threat Reduction Agency (DTRA) investment in Grant - Venatorx Pharmaceuticals
CARB-X
CARB-X investment in Grant - Venatorx Pharmaceuticals
Abingworth
Abingworth investment in Series B - Venatorx Pharmaceuticals
Versant Ventures
Versant Ventures investment in Series B - Venatorx Pharmaceuticals
BioAdvance
BioAdvance investment in Series B - Venatorx Pharmaceuticals
Foresite Capital
Foresite Capital investment in Series B - Venatorx Pharmaceuticals
Key Employee Changes
Date | New article |
---|---|
2021-12-02 | Venatorx Pharmaceuticals Names Scott McConnell, Pharm.D. as Vice President, Medical Affairs |
Official Site Inspections
http://www.venatorx.com
- Host name: 120.188.74.97.host.secureserver.net
- IP address: 97.74.188.120
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260